NIPO trademark

EMGALITY

RegisteredNIPOWord markClass 5

"EMGALITY" is a word mark owned by Eli Lilly and Company, filed at the NIPO on November 6, 2017. It is registered and covers class 5 (Pharmaceuticals).

View Eli Lilly and Company portfolioGet this data via the API
Official NIPO record
EMGALITY
Word mark as filed with the NIPO
Status
Registered
Since March 19, 2018
Filed
November 6, 2017
Registered
March 19, 2018
Expires
November 6, 2027
Application no.
201714703
Registration no.
296929
Office
NIPO
Patentstyret (Norwegian Industrial Property Office)
Mark type
Word mark
1 class
Ownership

Who owns EMGALITY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Eli Lilly and Company

LLY · Indianapolis, United States

8,043 trademarks in the portfolioView company

Representative

Bryn Aarflot AS

Bryn Aarflot AS

Goods and services

What the mark covers

The products and services EMGALITY is filed for, grouped by Nice class.

  • Farmasøytiske preparater, nemlig farmasøytiske preparater for behandling av Alzheimers sykdom, angstlidelser, allergisk eksem, autoimmune sykdommer og lidelser, aksial spondylartritt, ben- og skjelettsykdommer og -lidelser, kreft, kardio-vaskulære sykdommer, sykdommer og forstyrrelser i sentralnervesystemet, cluster-hodepine, Crohns syksom, demens, dermatologiske sykdommer og forstyrrelser, diabetes, dyslipidemi, endokrine sykdommer og lidelser, gastrointestinale sykdommer og lidelser, hypoglykemi, betennelser og inflammatoriske sykdommer og lidelser, inflammatorisk tarmsykdom, nyresykdommer og -lidelser, leversykdommer og -lidelser, psykiske lidelser, metaboliske sykdommer og lidelser, migrene, multippel sklerose, muskelsykdommer og -lidelser, nevrodegenerative sykdommer og lidelser, nevrologiske lidelser, smerte, Parkinsons sykdom, psoriasis arthropatica, leddgikt, Sjøgrens syndrom, søvnforstyrrelser, spondylartropati, systemisk lupus erythematosus, ulcerøs kolitt, diagnostiske midler og stoffer for medisinske formål; radiofarmasøytiske diagnostiske preparater for bruk i diagnostiseringen av nevrodegenerative sykdommer.

History

What has happened so far

Steps recorded by the NIPO, newest first.

  1. Date of publication of a registered mark
FAQ

About EMGALITY

Who owns the trademark "EMGALITY"?

The NIPO trademark "EMGALITY" (application 201714703) is owned by Eli Lilly and Company.

What is the status of "EMGALITY"?

Its status at the NIPO is: registered.

When was "EMGALITY" registered?

It was registered on March 19, 2018 and is due to expire on November 6, 2027.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull EMGALITY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019e4bd3-ce66-70fc-bce8-405e879fa320
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019e4bd3-ce66-70fc-bce8-405e879fa320",
  "object": "trademark",
  "mark_text": "EMGALITY",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "NO",
  "application_number": "201714703",
  "filing_date": "2017-11-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
    }
  ]
}